Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients

Clinical trial NCT05683015 · UNKNOWN

Trial details

NCT number: NCT05683015
Sponsor: University Hospital, Ghent
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2022-08-22
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.